In vivo evaluation of [123I]-3-(4-iodobenzyl)-1,2,3,4-tetrahydro-8-hydroxychromeno[3,4-c]pyridin-5-one: a presumed dopamine D4 receptor ligand for SPECT studies
- 30 April 2005
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 32 (3) , 293-299
- https://doi.org/10.1016/j.nucmedbio.2004.12.006
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Dopamine D2 and D4 receptor ligands: relation to antipsychotic actionEuropean Journal of Pharmacology, 1998
- Antipsychotic drugs which elicit little or no Parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptorsMolecular Psychiatry, 1998
- Schizophrenia: elevation of dopamine D4-like sites, using [3H]nemonapride and [125I]epideprideEuropean Journal of Pharmacology, 1995
- Absence of detectable striatal dopamine D4 receptors in drug-treated schizophreniaEuropean Journal of Pharmacology, 1995
- Are Striatal Dopamine D4 Receptors Increased in Schizophrenia?Journal of Neurochemistry, 1994
- Dopamine D4 receptors elevated in schizophreniaNature, 1993
- Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and ClozapineArchives of General Psychiatry, 1992
- Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapineNature, 1991
- Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic DrugsScience, 1976
- Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine NeuronsScience, 1975